1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MOONLAKE IMMUNOTHERAPEUTICS - ORDINARY SHARES - CLASS A
MoonLake Immunotherapeutics - Ordinary Shares - Class A XNAS: MLTX

MoonLake Immunotherapeutics - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

about

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibit...

Read More
52.35 -2.12 (-3.89%)
339.2K
XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for MoonLake Immunotherapeutics - Ordinary Shares - Class A is on 07 Aug 2025 for the purpose of MoonLake Immunotherapeutics Second Quarter Earnings Results for 2025 See details
Not Eligible
-
Expensive Valuation
3.0 / 100
Technically Neutral
58.0 / 100

MoonLake Immunotherapeutic... Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..